GlassScriptPhysician profile
Lucia E Millet
NPI 1598076994
$5,411.37
in general payments reported to CMS, 2019-2025
24 companies · $1,443 in 2025
The $1,443 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547 · 2020: $142 · 2021: $493 · 2022: $504 · 2023: $822 · 2024: $1,460 · 2025: $1,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,725.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,826.10 | 2019-2025 | Eysuvis, Precision 1, Wavelight Ex500 Excimer Laser |
| Glaukos Corporation | $484.28 | 2023-2025 | Photrexa, Kxl System (Not Refurbished), Photrexa Viscous and Photrexa |
| Tarsus Pharmaceuticals, INC. | $433.48 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $360.62 | 2023-2025 | Xiidra, Miebo, Ic-8 Apthera Iol |
| Biotissue Holdings INC. | $338.88 | 2019-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $296.70 | 2019-2021 | |
| Ocular Therapeutix, INC. | $272.74 | 2021-2022 | |
| Dompe US, INC. | $175.76 | 2024-2025 | Oxervate |
| Kala Pharmaceuticals, INC. | $142.05 | 2021 | |
| Genzyme Corporation | $141.45 | 2024 | |
| Allergan, INC. | $132.58 | 2021-2022 | |
| Harrow Eye, LLC | $122.55 | 2024-2025 | Vevye |
| Aerie Pharmaceuticals, INC. | $122.49 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $119.97 | 2022-2024 | Acuvue |
| Coopervision INC. | $119.95 | 2019-2023 | Paragon Crt |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $81.79 | 2024 | Tearcare System |
| Visioneering Technologies, INC. | $48.24 | 2019 | |
| Rxsight INC | $38.36 | 2023 | Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Cartridge |
| Sun Pharmaceutical Industries INC. | $31.14 | 2025 | |
| Abbvie INC. | $29.87 | 2025 | |
| Rayner Intraocular Lenses Limited | $25.95 | 2025 | Rayner Cataract Set 1, Rayone Emv, Rayone Aspheric |
| Thea Pharma INC. | $22.72 | 2024 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $21.85 | 2023 | Flarex |
| Santen INC. | $21.85 | 2023 | Verkazia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucia Millet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.